197 related articles for article (PubMed ID: 27249075)
1. Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study.
Fontanella CA; Campo JV; Phillips GS; Hiance-Steelesmith DL; Sweeney HA; Tam K; Lehrer D; Klein R; Hurst M
J Clin Psychiatry; 2016 May; 77(5):661-7. PubMed ID: 27249075
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Tan Z; Wall MM; Mathai C; Olfson M
JAMA Psychiatry; 2019 May; 76(5):508-515. PubMed ID: 30785609
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.
Tiihonen J; Suokas JT; Suvisaari JM; Haukka J; Korhonen P
Arch Gen Psychiatry; 2012 May; 69(5):476-83. PubMed ID: 22566579
[TBL] [Abstract][Full Text] [Related]
4. Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.
Tiihonen J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Am J Psychiatry; 2016 Jun; 173(6):600-6. PubMed ID: 26651392
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
Baandrup L; Gasse C; Jensen VD; Glenthoj BY; Nordentoft M; Lublin H; Fink-Jensen A; Lindhardt A; Mortensen PB
J Clin Psychiatry; 2010 Feb; 71(2):103-8. PubMed ID: 19895781
[TBL] [Abstract][Full Text] [Related]
6. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
Ollendorf DA; Joyce AT; Rucker M
MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study.
Haro JM; Novick D; Suarez D; Roca M
J Psychiatr Res; 2009 Jan; 43(3):265-73. PubMed ID: 18644606
[TBL] [Abstract][Full Text] [Related]
9. Mortality and use of psychotropic medication in sleep apnoea patients: a population-wide register-based study.
Jennum P; Baandrup L; Tønnesen P; Ibsen R; Kjellberg J
Sleep Med; 2018 Mar; 43():19-24. PubMed ID: 29482806
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine use among patients with schizophrenia in Taiwan: a nationwide population-based survey.
Wu CS; Lin YJ; Liu SK
Psychiatr Serv; 2011 Aug; 62(8):908-14. PubMed ID: 21807830
[TBL] [Abstract][Full Text] [Related]
11. All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study.
Tenback D; Pijl B; Smeets H; Os Jv; Harten Pv
J Clin Psychopharmacol; 2012 Feb; 32(1):31-5. PubMed ID: 22198442
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepines, benzodiazepine-like drugs, and typical antipsychotics impair manual dexterity in patients with schizophrenia.
Sasayama D; Hori H; Teraishi T; Hattori K; Ota M; Matsuo J; Kinoshita Y; Okazaki M; Arima K; Amano N; Higuchi T; Kunugi H
J Psychiatr Res; 2014 Feb; 49():37-42. PubMed ID: 24262979
[TBL] [Abstract][Full Text] [Related]
13. [Mortality and cumulative exposure to antipsychotics, antidepressants and benzodiazepines in patients with schizophrenia: an observational follow-up study].
Tiihonenl J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Duodecim; 2016; 132(2):181. PubMed ID: 26939492
[No Abstract] [Full Text] [Related]
14. Risk of ischemic stroke associated with the use of antipsychotic drugs in elderly patients: a retrospective cohort study in Korea.
Shin JY; Choi NK; Lee J; Seong JM; Park MJ; Lee SH; Park BJ
PLoS One; 2015; 10(3):e0119931. PubMed ID: 25790285
[TBL] [Abstract][Full Text] [Related]
15. Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals.
Geffen J; Sorensen L; Stokes J; Cameron A; Roberts MS; Geffen L
Aust N Z J Psychiatry; 2002 Oct; 36(5):649-56. PubMed ID: 12225449
[TBL] [Abstract][Full Text] [Related]
16. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
Rossom RC; Rector TS; Lederle FA; Dysken MW
J Am Geriatr Soc; 2010 Jun; 58(6):1027-34. PubMed ID: 20487081
[TBL] [Abstract][Full Text] [Related]
17. Guideline-concordant antipsychotic use and mortality in schizophrenia.
Cullen BA; McGinty EE; Zhang Y; Dosreis SC; Steinwachs DM; Guallar E; Daumit GL
Schizophr Bull; 2013 Sep; 39(5):1159-68. PubMed ID: 23112292
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up.
Kiviniemi M; Suvisaari J; Koivumaa-Honkanen H; Häkkinen U; Isohanni M; Hakko H
Schizophr Res; 2013 Oct; 150(1):274-80. PubMed ID: 23953217
[TBL] [Abstract][Full Text] [Related]
19. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008.
Tor PC; Ng TP; Yong KH; Sim K; Xiang YT; Wang CY; Lee EH; Fujii S; Yang SY; Chong MY; Ungvari GS; Si T; He YL; Chung EK; Chee KY; Trivedi J; Udomratn P; Shinfuku N; Kua EH; Tan CH; Sartorius N; Baldessarini RJ
Int J Neuropsychopharmacol; 2011 Jul; 14(6):735-45. PubMed ID: 21294941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
